Molecular Determinants of KCNQ (Kv7) K+Channel Sensitivity to the Anticonvulsant Retigabine
Models, Molecular
0301 basic medicine
Patch-Clamp Techniques
KCNQ2/KCNQ3
Microinjections
Phenylenediamines
Membrane Potentials
03 medical and health sciences
IDIOPATHIC EPILEPSY
Animals
Humans
Point Mutation
TRAFFICKING
Cloning, Molecular
Dose-Response Relationship, Drug
KCNQ Potassium Channels
Tryptophan
Dose-Response Relationship, Radiation
SUBUNITS
Electric Stimulation
Protein Structure, Tertiary
Mutagenesis
Oocytes
POTASSIUM CHANNEL
Anticonvulsants
Carbamates
Sequence Alignment
DOI:
10.1523/jneurosci.0128-05.2005
Publication Date:
2005-05-18T18:28:49Z
AUTHORS (7)
ABSTRACT
Epilepsy is caused by an electrical hyperexcitability in the CNS. Because K + channels are critical for establishing and stabilizing resting potential of neurons, a loss could support neuronal hyperexcitability. Indeed, benign familial neonatal convulsions, autosomal dominant epilepsy infancy, mutations KCNQ2 or KCNQ3 channel genes. these contribute to native muscarinic-sensitive current (M current) that regulates excitability numerous types KCNQ (K v 7) activators would be effective treatment. A compound exhibiting anticonvulsant activity animal seizure models retigabine. It specifically acts on neuronally expressed KCNQ2-KCNQ5 7.2-K 7.5) channels, whereas KCNQ1 7.1) not affected. Using differential sensitivity retigabine, we constructed chimeras identify minimal segments required drug. We identified single tryptophan residue within S5 segment also KCNQ2, KCNQ4, KCNQ5 as crucial effect Furthermore, heteromeric comprising transmembrane domains (attributable transfer assembly properties from KCNQ1) retigabine insensitive. Transfer into scaffold resulted retigabine-sensitive heteromers, suggesting necessary all subunits forming functional tetramer confer drug sensitivity.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (33)
CITATIONS (223)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....